High-purity bioactive matrices paired with Pyrroloquinoline Quinone for targeted cardiovascular and longevity formulations
Unlocking the combined biological mechanisms of Pyrroloquinoline Quinone (PQQ) and trans-Resveratrol in myocardial cells
PQQ acts as an exceptional enzyme cofactor that triggers the cAMP response element-binding protein (CREB) and nuclear respiratory factors (NRF-1, NRF-2), accelerating spontaneous mitochondrial fission and biogenesis inside high-workload cardiomyocytes.
Trans-resveratrol functions as a natural sirtuin-1 (SIRT1) activator, stimulating deacetylation cascades that activate endothelial nitric oxide synthase (eNOS). This mechanism maintains basal vasodilation and reduces microvascular arterial rigidity.
Unlike standard polyphenols that deplete rapidly during free radical neutralization, PQQ displays phenomenal catalytic recycling capacity—undergoing thousands of redox cycles without degradation to suppress myocardial lipid peroxidation.
Cardiovascular disease pathology is fundamentally tied to mitochondrial decay, oxidative stress, and chronic micro-endothelial inflammation. Cardiomyocytes contain the highest density of mitochondria in human anatomy, consuming over 40% of cellular volume to generate continuous adenosine triphosphate (ATP) for contractile rhythm. When endogenous antioxidant defenses wane, accumulated reactive oxygen species (ROS) trigger mitochondrial DNA lesions, leading to cardiomyocyte senescence and vascular stiffness.
Formulating high-purity Pyrroloquinoline Quinone (PQQ) Powder directly into trans-Resveratrol-based softgels introduces a breakthrough therapeutic dynamic: the "Dual-Engine Mitochondrial Biogenesis & Endothelial Defense Matrix." Resveratrol targets longevity gene transcription via SIRT1-dependent pathways, priming cellular resilience and downregulating pro-inflammatory NF-κB signaling. Concurrently, PQQ operates directly inside the mitochondrial respiratory chain as an electron conduit, catalyzing the repair of dysfunctional respiratory complexes I and II. Together, this synergistic formulation produces statistically verified improvements in cardiac output, flow-mediated dilation (FMD), and myocardial oxidative threshold compared to mono-substance therapies.
Resolving phase separation, micro-suspension rheology, and bio-distribution in modern nutraceutical manufacturing
Industrial chemists face significant physicochemical challenges when combining PQQ disodium salt with trans-resveratrol. Resveratrol is hydrophobic (logP ~3.1) with low intrinsic water solubility, whereas PQQ disodium salt is moderately hydrophilic and prone to hygroscopic clumping. Achieving a homogenous, physically stable softgel inner suspension demands advanced micro-encapsulation techniques.
Cross-linking of gelatin ribbons caused by reactive carbonyl moieties represents a common mode of softgel failure. PQQ features multiple carbonyl functional groups that can potentially react with lysine residues in standard bovine gelatin, leading to shell pellicle formation and impaired dissolution kinetics.
Strategic B2B market intelligence for finished dosage manufacturers, private label brands, and R&D developers
The global cardiovascular health supplements market is projected to surpass USD 19.8 billion by 2030, charting an aggressive CAGR of 8.4%. Historically dominated by basic Omega-3 fish oils and Coenzyme Q10 (CoQ10), consumer demand has pivoted radically toward scientifically authenticated anti-aging interventions. "Cellular Longevity" and "Mitochondrial Rejuvenation" have emerged as the fastest-growing claims across North American, European, and Asia-Pacific nutraceutical markets.
Formulators are rapidly replacing mono-ingredient heart formulas with integrated cellular cocktails. In this competitive landscape, the marriage of Pyrroloquinoline Quinone Powder and Resveratrol in a single hermetically sealed softgel represents the apex of value-added positioning. While CoQ10 functions merely as a cofactor, PQQ actually promotes the de novo synthesis of brand-new mitochondria—a distinct biological advantage that resonates with educated, health-conscious demographics searching for premium cardioprotection.
Precision delivery concepts engineered for distinct therapeutic niches across global health sectors
Tailored for adults aged 45+ experiencing arterial stiffening, systolic elevation, or peripheral microcirculation decline. Daily dosing of 20mg bio-fermented PQQ disodium salt with 250mg trans-resveratrol in an olive oil lipid vehicle supports natural vascular flexibility and nitric oxide reserve.
Targeted at endurance athletes and high-performance individuals subject to prolonged exercise-induced myocardial strain. Combining PQQ and Resveratrol mitigates post-training cardiac troponin elevations, blunts strenuous oxidative damage, and shortens physical replenishment intervals.
Created for individuals combating metabolic syndrome, dyslipidemia, or age-related mental fatigue. The synergistic duo concurrently traverses the blood-brain barrier and coronary micro-vessels, providing concurrent neuro-protection, cerebral perfusion, and healthy myocardial oxygenation.
Pioneering Natural Raw Materials, Specialized Botanical Extraction, and Turnkey Nutritional Solutions
We are dedicated to the research, production and marketing of Natural, healthy and innovative raw materials widely used in the fields of Nutraceuticals, Foods and Beverages, Cosmetics&Personal Care Products.
We boast a broad product range that includes Botanical Extracts, Plant Proteins, protein hydrolysate actives, moisturizing, emollient, Surfactants, etc. With over 10 years of export experience and World-Renowned Customer Cooperation Cases, we have accumulated expert knowledge of this field. Our High-Quality Ingredients and Professional Service have been highly recognized by our customers from over 40 countries, like USA, Canada, UK, France, Germany, Switzerland, Spain, Netherlands, Belgium, Sweden, Thailand, Philippines, Japan, Korea, Russia, Singapore, Indonesia, Brazil, and beyond.
We have advanced large-scale production equipment and diversified production lines. The facility covers 60,000 square meters with an annual raw material production capacity of 3,000 tons. 6 multifunctional production lines are equipped with different types of extraction tanks, contributing to the process of a wide range of plant materials and the production of raw materials with diversified purities and applications.










Explore our certified raw materials and active botanical extracts manufactured under strict cGMP protocols
Exceeding international pharmacopoeial standards through rigorous in-house HPLC, LC-MS, and ICP-MS assay verification
At Xi’an Le-Nutra Ingredients Inc, our high-purity Pyrroloquinoline Quinone Powder is produced via precision bacterial fermentation using selected food-grade bacterial strains. This bio-fermentation process replicates the natural biochemical form of PQQ found in human mother's milk, kiwi, and natto, providing superior biocompatibility and cellular assimilation compared to non-stereospecific chemical synthesis.
Every single manufacturing batch undergoes multi-dimensional quality assays before release, including:
By marrying state-of-the-art biological synthesis with a 60,000 square meter cGMP extraction infrastructure, Xi'an Le-Nutra Ingredients Inc delivers unparalleled raw material consistency, ensuring your Resveratrol-Based Cardiovascular Support Softgels satisfy stringent global regulatory frameworks across the United States, European Union, and Asia.